MedTrace Logo

The Diagnostic Value of 18F-FET PET/MRI for CNS Tumors in Children and Adolescents

NCT03402425 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-03-28

No results posted yet for this study

Summary

To investigate the diagnostic value of 18F-FET PET/MRI instead of MRI alone, children and adolescents with tumor in brain or spinal cord are included and scanned primarily at our hybrid PET/MRI using the amino acid analog 18F-FET. The scans are performed at primary diagnosis, before radiation therapy, before and after operation, when relapse is suspected and three or six months after initiation of chemotherapy.

Conditions

  • Positron-Emission Tomography
  • Brain Neoplasms, Childhood

Interventions

DIAGNOSTIC_TEST

18F-FET PET

Patient are investigated with an 18F-FET PET

Sponsors & Collaborators

  • Børnecancerfonden

    collaborator OTHER

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Lisbeth Marner, MD PhD DMSc · Rigshospitalet, Denmark

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-24
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03402425 on ClinicalTrials.gov